Product Name

  • Name

    Bifonazole

  • EINECS 262-336-6
  • CAS No. 60628-96-8
  • Article Data15
  • CAS DataBase
  • Density 1.077 g/cm3
  • Solubility
  • Melting Point 142℃
  • Formula C22H18N2
  • Boiling Point 491.728 °C at 760 mmHg
  • Molecular Weight 310.398
  • Flash Point 251.188 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes 22
  • Molecular Structure Molecular Structure of 60628-96-8 (Bifonazole)
  • Hazard Symbols Xn
  • Synonyms 1-[4-Biphenylyl(phenyl)methyl]-1H-imidazole;
  • PSA 17.82000
  • LogP 5.18780

Synthetic route

(R,S)-1-<α-(4-Biphenylyl)benzyl>imidazole-4,5-dicarboxylic acid
162824-42-2

(R,S)-1-<α-(4-Biphenylyl)benzyl>imidazole-4,5-dicarboxylic acid

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
In diphenylether for 0.5h; Heating;98%
1H-imidazole
288-32-4

1H-imidazole

4-benzylbiphenyl
613-42-3

4-benzylbiphenyl

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Stage #1: 4-benzylbiphenyl With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane for 0.833333h; Inert atmosphere; Reflux;
Stage #2: 1H-imidazole With potassium carbonate In acetonitrile for 1h; Reflux;
77%
Stage #1: 4-benzylbiphenyl With pyridine; tert.-butylhydroperoxide; iodine In decane; water at 80℃; for 12h; Schlenk technique; Inert atmosphere;
Stage #2: 1H-imidazole With formic acid; toluene-4-sulfonic acid In water at 180 - 200℃; for 10h; Schlenk technique; Inert atmosphere;
66%
1H-imidazole
288-32-4

1H-imidazole

C26H21N2O2S(1-)*Na(1+)

C26H21N2O2S(1-)*Na(1+)

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
With copper acetylacetonate; tetrabutylammomium bromide In toluene at 85℃; for 36h;52%
4-phenylbenzhydrol
7598-80-3

4-phenylbenzhydrol

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
In 1-methyl-pyrrolidin-2-one Heating;12%
phenylmagnesium bromide

phenylmagnesium bromide

1-[(4-methoxy-phenyl)-phenyl-methyl]-1H-imidazole

1-[(4-methoxy-phenyl)-phenyl-methyl]-1H-imidazole

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
With bis(dicyclohexylphenylphosphine)nickel(II) chloride In diethyl ether at 80℃; for 15h;
4-phenylbenzhydrol
7598-80-3

4-phenylbenzhydrol

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 96 percent / DEAD, Ph3P / tetrahydrofuran / 24 h / Ambient temperature
2: 85 percent / NaOH / ethanol / 24 h / Heating
3: 98 percent / diphenyl ether / 0.5 h / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: triethylamine / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
2.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 2 h / 0 °C / Inert atmosphere
2.2: 0 - 100 °C / Inert atmosphere
View Scheme
1-<α-(4-Biphenylyl)benzyl>imidazole-4,5-dicarbonitrile
162824-36-4

1-<α-(4-Biphenylyl)benzyl>imidazole-4,5-dicarbonitrile

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / NaOH / ethanol / 24 h / Heating
2: 98 percent / diphenyl ether / 0.5 h / Heating
View Scheme
4-(chlorophenylmethyl)-1,1'-biphenyl
7515-73-3

4-(chlorophenylmethyl)-1,1'-biphenyl

1-(Trimethylsilyl)imidazole
18156-74-6

1-(Trimethylsilyl)imidazole

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
In acetonitrile
1H-imidazole
288-32-4

1H-imidazole

4-phenylbenzhydrol
7598-80-3

4-phenylbenzhydrol

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Stage #1: 1H-imidazole; 4-phenylbenzhydrol With ammonium bromide In water at 125 - 130℃; for 2h; Industrial scale;
Stage #2: With ammonium bromide In water at 190 - 195℃; for 2h; Temperature; Industrial scale;
trimethylphenylsilane
768-32-1

trimethylphenylsilane

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: silver(I) 4-methylbenzenesulfonate; dichloro(N-(diphenylphosphino)-N-isopropyl-1,1-diphenylphosphinamine) digold(I); [bis(acetoxy)iodo]benzene / 1,1,1-trichloroethane / 2 h / 110 °C / Inert atmosphere; Schlenk technique
2.1: aluminum oxide; sodium tetrahydroborate / ethanol / 0.67 h / 20 °C / Inert atmosphere
3.1: triethylamine / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
4.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 2 h / 0 °C / Inert atmosphere
4.2: 0 - 100 °C / Inert atmosphere
View Scheme
(4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)(phenyl)methanone
1063965-82-1

(4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)(phenyl)methanone

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: silver(I) 4-methylbenzenesulfonate; dichloro(N-(diphenylphosphino)-N-isopropyl-1,1-diphenylphosphinamine) digold(I); [bis(acetoxy)iodo]benzene / 1,1,1-trichloroethane / 2 h / 110 °C / Inert atmosphere; Schlenk technique
2.1: aluminum oxide; sodium tetrahydroborate / ethanol / 0.67 h / 20 °C / Inert atmosphere
3.1: triethylamine / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
4.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 2 h / 0 °C / Inert atmosphere
4.2: 0 - 100 °C / Inert atmosphere
View Scheme
biphenyl-4-yl-phenyl-methanone
2128-93-0

biphenyl-4-yl-phenyl-methanone

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: aluminum oxide; sodium tetrahydroborate / ethanol / 0.67 h / 20 °C / Inert atmosphere
2.1: triethylamine / dichloromethane / 2 h / 0 - 20 °C / Inert atmosphere
3.1: sodium hydride / N,N-dimethyl-formamide; mineral oil / 2 h / 0 °C / Inert atmosphere
3.2: 0 - 100 °C / Inert atmosphere
View Scheme
1H-imidazole
288-32-4

1H-imidazole

[1,1'-biphenyl]-4-yl(phenyl)methyl methanesulfonate

[1,1'-biphenyl]-4-yl(phenyl)methyl methanesulfonate

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Stage #1: 1H-imidazole With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 2h; Inert atmosphere;
Stage #2: [1,1'-biphenyl]-4-yl(phenyl)methyl methanesulfonate In N,N-dimethyl-formamide; mineral oil at 0 - 100℃; Inert atmosphere;
61.9 mg
Diphenylmethane
101-81-5

Diphenylmethane

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: dichloromethane / -40 - 20 °C / Schlenk technique; Inert atmosphere
2: bis(tri-t-butylphosphine)palladium(0); sodium hydrogencarbonate / dichloromethane; N,N-dimethyl-formamide / 12 h / 50 °C / Inert atmosphere; Schlenk technique
3: 2,2'-azobis(isobutyronitrile); N-Bromosuccinimide / tetrachloromethane / 0.83 h / Inert atmosphere; Reflux
4: potassium carbonate / acetonitrile / 1 h / Reflux
View Scheme
Multi-step reaction with 3 steps
1.1: dichloromethane / -40 - 20 °C / Inert atmosphere; Schlenk technique
2.1: sodium hydrogencarbonate; bis(tri-t-butylphosphine)palladium(0) / dichloromethane; N,N-dimethyl-formamide / 12 h / 50 °C / Inert atmosphere; Schlenk technique; Sealed tube
3.1: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / tetrachloromethane / 0.83 h / Inert atmosphere; Reflux
3.2: 1 h / Reflux
View Scheme
C25H19S2(1+)*CF3O3S(1-)

C25H19S2(1+)*CF3O3S(1-)

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: bis(tri-t-butylphosphine)palladium(0); sodium hydrogencarbonate / dichloromethane; N,N-dimethyl-formamide / 12 h / 50 °C / Inert atmosphere; Schlenk technique
2: 2,2'-azobis(isobutyronitrile); N-Bromosuccinimide / tetrachloromethane / 0.83 h / Inert atmosphere; Reflux
3: potassium carbonate / acetonitrile / 1 h / Reflux
View Scheme
1H-imidazole
288-32-4

1H-imidazole

4-phenyl-benzhydryl bromide
60047-92-9

4-phenyl-benzhydryl bromide

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 1h; Reflux;47.9 mg
4-benzylbiphenyl
613-42-3

4-benzylbiphenyl

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2,2'-azobis(isobutyronitrile); N-Bromosuccinimide / tetrachloromethane / 0.83 h / Inert atmosphere; Reflux
2: potassium carbonate / acetonitrile / 1 h / Reflux
View Scheme
2-phenyl-4,4,5,5-tetramethyl-1,3,2-dioxoborole
24388-23-6

2-phenyl-4,4,5,5-tetramethyl-1,3,2-dioxoborole

C25H19S2(1+)*CF3O3S(1-)

C25H19S2(1+)*CF3O3S(1-)

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: sodium hydrogencarbonate; bis(tri-t-butylphosphine)palladium(0) / dichloromethane; N,N-dimethyl-formamide / 12 h / 50 °C / Inert atmosphere; Schlenk technique; Sealed tube
2.1: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / tetrachloromethane / 0.83 h / Inert atmosphere; Reflux
2.2: 1 h / Reflux
View Scheme
N-trifluoromethanesulfony-4-benzylaniline

N-trifluoromethanesulfony-4-benzylaniline

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: tetrahydrofuran / 0.08 h / 20 °C / Schlenk technique; Inert atmosphere
1.2: 12.03 h / 70 °C / Schlenk technique; Inert atmosphere; Glovebox
2.1: iodine; pyridine; tert.-butylhydroperoxide / water; decane / 12 h / 80 °C / Schlenk technique; Inert atmosphere
2.2: 10 h / 180 - 200 °C / Schlenk technique; Inert atmosphere
View Scheme
p-benzylaniline
1135-12-2

p-benzylaniline

bifonazole
60628-96-8

bifonazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: triethylamine / dichloromethane / 12.5 h / -78 - 20 °C / Schlenk technique; Inert atmosphere
2.1: tetrahydrofuran / 0.08 h / 20 °C / Schlenk technique; Inert atmosphere
2.2: 12.03 h / 70 °C / Schlenk technique; Inert atmosphere; Glovebox
3.1: iodine; pyridine; tert.-butylhydroperoxide / water; decane / 12 h / 80 °C / Schlenk technique; Inert atmosphere
3.2: 10 h / 180 - 200 °C / Schlenk technique; Inert atmosphere
View Scheme
tetrafluoroboric acid diethyl ether
67969-82-8

tetrafluoroboric acid diethyl ether

sodium tetrafluoroborate
13755-29-8

sodium tetrafluoroborate

thianthrene-5-oxide
2362-50-7

thianthrene-5-oxide

bifonazole
60628-96-8

bifonazole

C34H25N2S2(1+)*BF4(1-)

C34H25N2S2(1+)*BF4(1-)

Conditions
ConditionsYield
Stage #1: tetrafluoroboric acid diethyl ether; thianthrene-5-oxide; bifonazole With trifluoroacetic anhydride In acetonitrile at 0 - 25℃; for 18h; Schlenk technique;
Stage #2: sodium tetrafluoroborate In dichloromethane; water
95%
Ethyl 4-bromobenzoate
5798-75-4

Ethyl 4-bromobenzoate

bifonazole
60628-96-8

bifonazole

ethyl 4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzoate

ethyl 4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzoate

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;90%
2,3,7,8-tetrafluorothianthrene-S-oxide

2,3,7,8-tetrafluorothianthrene-S-oxide

bifonazole
60628-96-8

bifonazole

C34H21F4N2S2(1+)

C34H21F4N2S2(1+)

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; 2,3,7,8-tetrafluorothianthrene; trifluoroacetic anhydride In acetonitrile at 0 - 25℃; regioselective reaction;87%
trifluorormethanesulfonic acid
1493-13-6

trifluorormethanesulfonic acid

2,3,7,8-tetrafluorothianthrene-S-oxide

2,3,7,8-tetrafluorothianthrene-S-oxide

sodium triflate
2926-30-9

sodium triflate

bifonazole
60628-96-8

bifonazole

C34H21F4N2S2(1+)*CF3O3S(1-)

C34H21F4N2S2(1+)*CF3O3S(1-)

Conditions
ConditionsYield
Stage #1: trifluorormethanesulfonic acid; 2,3,7,8-tetrafluorothianthrene-S-oxide; bifonazole With trifluoroacetic anhydride In acetonitrile at 0 - 25℃; for 3h; Sealed tube;
Stage #2: sodium triflate In ethanol; dichloromethane; water
87%
4'-Bromopropiophenone
10342-83-3

4'-Bromopropiophenone

bifonazole
60628-96-8

bifonazole

1-(4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)phenyl)propan-1-one

1-(4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)phenyl)propan-1-one

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;77%
4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

bifonazole
60628-96-8

bifonazole

4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzaldehyde

4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzaldehyde

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;77%
3-bromo-1-trifluoromethylbenzene
401-78-5

3-bromo-1-trifluoromethylbenzene

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(3-(trifluoromethyl)phenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(3-(trifluoromethyl)phenyl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;71%
p-trifluoromethylphenyl bromide
402-43-7

p-trifluoromethylphenyl bromide

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-(trifluoromethyl)phenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-(trifluoromethyl)phenyl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;66%
Dibenzothiophene sulfoxide
1013-23-6

Dibenzothiophene sulfoxide

trifluorormethanesulfonic acid
1493-13-6

trifluorormethanesulfonic acid

bifonazole
60628-96-8

bifonazole

C34H25N2S(1+)*CF3O3S(1-)

C34H25N2S(1+)*CF3O3S(1-)

Conditions
ConditionsYield
With trifluoroacetic anhydride In acetonitrile at -40 - 25℃; for 2h; Schlenk technique; Glovebox; Inert atmosphere;65%
4-bromoisoquinoline
1532-97-4

4-bromoisoquinoline

bifonazole
60628-96-8

bifonazole

4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)isoquinoline

4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)isoquinoline

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;63%
4-bromobenzenecarbonitrile
623-00-7

4-bromobenzenecarbonitrile

bifonazole
60628-96-8

bifonazole

4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)-benzonitrile

4-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)-benzonitrile

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;61%
3-cyanobromobenzene
6952-59-6

3-cyanobromobenzene

bifonazole
60628-96-8

bifonazole

3-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzonitrile

3-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzonitrile

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;61%
2-Acetyl-5-bromothiophene
5370-25-2

2-Acetyl-5-bromothiophene

bifonazole
60628-96-8

bifonazole

1-(5-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)thiophen-2-yl)ethan-1-one

1-(5-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)thiophen-2-yl)ethan-1-one

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;59%
o-cyanobromobenzene
2042-37-7

o-cyanobromobenzene

bifonazole
60628-96-8

bifonazole

2-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzonitrile

2-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)benzonitrile

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;58%
para-bromotoluene
106-38-7

para-bromotoluene

bifonazole
60628-96-8

bifonazole

A

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-2,5-di-p-tolyl-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-2,5-di-p-tolyl-1H-imidazole

B

C29H24N2

C29H24N2

Conditions
ConditionsYield
With cesium acetate; palladium diacetate at 150℃; for 48h; Inert atmosphere; Schlenk technique;A 58%
B n/a
1-bromo-4-methoxy-benzene
104-92-7

1-bromo-4-methoxy-benzene

bifonazole
60628-96-8

bifonazole

A

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-2,5-bis(4-methoxyphenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-2,5-bis(4-methoxyphenyl)-1H-imidazole

B

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-methoxyphenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-methoxyphenyl)-1H-imidazole

Conditions
ConditionsYield
With cesium acetate; palladium diacetate at 150℃; for 48h; Inert atmosphere; Schlenk technique;A 57%
B n/a
bromobenzene
108-86-1

bromobenzene

bifonazole
60628-96-8

bifonazole

A

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-2,5-diphenyl-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-2,5-diphenyl-1H-imidazole

B

C28H22N2

C28H22N2

Conditions
ConditionsYield
With cesium acetate; palladium diacetate at 150℃; for 48h; Inert atmosphere; Schlenk technique;A 55%
B n/a
[(Co(C20H8N4(C6H5)3(C6H4CONH2)))2]

[(Co(C20H8N4(C6H5)3(C6H4CONH2)))2]

bifonazole
60628-96-8

bifonazole

Co(O(C4NH2C(C6H5))3H(OH)C4NH2C6H4C2NO)(bifonazole)

Co(O(C4NH2C(C6H5))3H(OH)C4NH2C6H4C2NO)(bifonazole)

Conditions
ConditionsYield
With air In chloroform treatment of Co-complex with rac-bifonazole; XRD, UV-Vis;46%
o-trifluoromethylphenyl bromide
392-83-6

o-trifluoromethylphenyl bromide

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(2-(trifluoromethyl)phenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(2-(trifluoromethyl)phenyl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;45%
3-Chloropyridine
626-60-8

3-Chloropyridine

bifonazole
60628-96-8

bifonazole

3-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)pyridine

3-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)pyridine

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;45%
bifonazole
60628-96-8

bifonazole

para-nitrophenyl bromide
586-78-7

para-nitrophenyl bromide

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-nitrophenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-nitrophenyl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;43%
1-Bromonaphthalene
90-11-9

1-Bromonaphthalene

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(naphthalen-1-yl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(naphthalen-1-yl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;42%
5-bromopyrimidine
4595-59-9

5-bromopyrimidine

bifonazole
60628-96-8

bifonazole

5-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)pyrimidine

5-(1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-1H-imidazol-5-yl)pyrimidine

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;41%
2-bromonaphthalene
580-13-2

2-bromonaphthalene

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(naphthalen-2-yl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(naphthalen-2-yl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;39%
1-bromo-4-tert-butylbenzene
3972-65-4

1-bromo-4-tert-butylbenzene

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-(tert-butyl)-phenyl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(4-(tert-butyl)-phenyl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;34%
1,2-(methylenedioxy)-4-bromobenzene
2635-13-4

1,2-(methylenedioxy)-4-bromobenzene

bifonazole
60628-96-8

bifonazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(benzo[d][1,3]-dioxol-5-yl)-1H-imidazole

1-([1,1′-biphenyl]-4-yl(phenyl)methyl)-5-(benzo[d][1,3]-dioxol-5-yl)-1H-imidazole

Conditions
ConditionsYield
With potassium acetate; palladium diacetate at 150℃; for 16h; Inert atmosphere; Schlenk technique;28%

Bifonazole Specification

The Bifonazole, with the CAS registry number 60628-96-8, is also known as 1-[4-Biphenylyl(phenyl)methyl]-1H-imidazole. It belongs to the classification codes of Anti-Infective Agents; Antifungal; Antifungal Agents; Drug / Therapeutic Agent; Reproductive Effect. Its EINECS registry number is 262-336-6. This chemical's molecular formula is C22H18N2 and molecular weight is 310.39. What's more, its IUPAC name is called 1-[Phenyl-(4-phenylphenyl)methyl]imidazole. It should be stored in a cool, dry and well-ventilated place. Bifonazole is topical imidazole antifungal drug for the treatment of a variety of dermatophytoses, such as tinea corporis, tinea cruris, hand, foot and ringworm.

Physical properties about Bifonazole are: (1)ACD/LogP: 4.689; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 3.62; (4)ACD/LogD (pH 7.4): 4.63; (5)ACD/BCF (pH 5.5): 182.76; (6)ACD/BCF (pH 7.4): 1890.91; (7)ACD/KOC (pH 5.5): 717.78; (8)ACD/KOC (pH 7.4): 7426.47; (9)#H bond acceptors: 2; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 17.82 Å2; (13)Index of Refraction: 1.616; (14)Molar Refractivity: 100.752 cm3; (15)Molar Volume: 288.133 cm3; (16)Polarizability: 39.941×10-24cm3; (17)Surface Tension: 43.15 dyne/cm; (18)Density: 1.077 g/cm3; (19)Flash Point: 251.188 °C; (20)Enthalpy of Vaporization: 72.969 kJ/mol; (21)Boiling Point: 491.728 °C at 760 mmHg; (22)Vapour Pressure: 0 mmHg at 25 °C.

Preparation of Bifonazole: this chemical can be prepared by imidazole with thionyl chloride. This reaction needs reagent acetonitrile at ambient temperature. The reaction time is 15 hours.

Bifonazole can be prepared by imidazole with thionyl chloride.

You can still convert the following datas into molecular structure:
(1) SMILES: n1ccn(c1)C(c3ccc(c2ccccc2)cc3)c4ccccc4
(2) InChI: InChI=1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H
(3) InChIKey: OCAPBUJLXMYKEJ-UHFFFAOYSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 oral > 500mg/kg (500mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 33, Pg. 739, 1983.
mouse LD50 intravenous 57mg/kg (57mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 23, 1984.
mouse LD50 oral 2629mg/kg (2629mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 33, Pg. 739, 1983.
mouse LD50 subcutaneous > 15gm/kg (15000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 23, 1984.
rabbit LD50 oral 4gm/kg (4000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 33, Pg. 739, 1983.
rat LD50 intravenous 63mg/kg (63mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 23, 1984.
rat LD50 oral 1463mg/kg (1463mg/kg) SKIN AND APPENDAGES (SKIN): HAIR: OTHER

BEHAVIORAL: ATAXIA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 23, 1984.
rat LD50 subcutaneous > 10gm/kg (10000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"
Oyo Yakuri. Pharmacometrics. Vol. 28, Pg. 23, 1984.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View